» Articles » PMID: 28800611

Using Local Chromatin Structure to Improve CRISPR/Cas9 Efficiency in Zebrafish

Overview
Journal PLoS One
Date 2017 Aug 12
PMID 28800611
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Although the CRISPR/Cas9 has been successfully applied in zebrafish, considerable variations in efficiency have been observed for different gRNAs. The workload and cost of zebrafish mutant screening is largely dependent on the mutation rate of injected embryos; therefore, selecting more effective gRNAs is especially important for zebrafish mutant construction. Besides the sequence features, local chromatin structures may have effects on CRISPR/Cas9 efficiency, which remain largely unexplored. In the only related study in zebrafish, nucleosome organization was not found to have an effect on CRISPR/Cas9 efficiency, which is inconsistent with recent studies in vitro and in mammalian cell lines. To understand the effects of local chromatin structure on CRISPR/Cas9 efficiency in zebrafish, we first determined that CRISPR/Cas9 introduced genome editing mainly before the dome stage. Based on this observation, we reanalyzed our published nucleosome organization profiles and generated chromatin accessibility profiles in the 256-cell and dome stages using ATAC-seq technology. Our study demonstrated that chromatin accessibility showed positive correlation with CRISPR/Cas9 efficiency, but we did not observe a clear correlation between nucleosome organization and CRISPR/Cas9 efficiency. We constructed an online database for zebrafish gRNA selection based on local chromatin structure features that could prove beneficial to zebrafish homozygous mutant construction via CRISPR/Cas9.

Citing Articles

Establishment of a zebrafish inbred strain, M-AB, capable of regular breeding and genetic manipulation.

Sadamitsu K, Velilla F, Shinya M, Kashima M, Imai Y, Kawasaki T Sci Rep. 2024; 14(1):7455.

PMID: 38548817 PMC: 10978973. DOI: 10.1038/s41598-024-57699-3.


Quantum biological insights into CRISPR-Cas9 sgRNA efficiency from explainable-AI driven feature engineering.

Noshay J, Walker T, Alexander W, Klingeman D, Romero J, Walker A Nucleic Acids Res. 2023; 51(19):10147-10161.

PMID: 37738140 PMC: 10602897. DOI: 10.1093/nar/gkad736.


Trichostatin A for Efficient CRISPR-Cas9 Gene Editing of Human Pluripotent Stem Cells.

Molugu K, Khajanchi N, Lazzarotto C, Tsai S, Saha K CRISPR J. 2023; 6(5):473-485.

PMID: 37676985 PMC: 10611976. DOI: 10.1089/crispr.2023.0033.


Novel extragenic genomic safe harbors for precise therapeutic T-cell engineering.

Odak A, Yuan H, Feucht J, Cantu V, Mansilla-Soto J, Kogel F Blood. 2023; 141(22):2698-2712.

PMID: 36745870 PMC: 10273162. DOI: 10.1182/blood.2022018924.


Comprehensive computational analysis of epigenetic descriptors affecting CRISPR-Cas9 off-target activity.

Mak J, Stortz F, Minary P BMC Genomics. 2022; 23(1):805.

PMID: 36474180 PMC: 9724382. DOI: 10.1186/s12864-022-09012-7.


References
1.
Wu X, Scott D, Kriz A, Chiu A, Hsu P, Dadon D . Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells. Nat Biotechnol. 2014; 32(7):670-6. PMC: 4145672. DOI: 10.1038/nbt.2889. View

2.
Dooley K, Zon L . Zebrafish: a model system for the study of human disease. Curr Opin Genet Dev. 2000; 10(3):252-6. DOI: 10.1016/s0959-437x(00)00074-5. View

3.
Langmead B, Salzberg S . Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012; 9(4):357-9. PMC: 3322381. DOI: 10.1038/nmeth.1923. View

4.
Shah A, Davey C, Whitebirch A, Miller A, Moens C . Rapid reverse genetic screening using CRISPR in zebrafish. Nat Methods. 2015; 12(6):535-40. PMC: 4667794. DOI: 10.1038/nmeth.3360. View

5.
McKenna A, Findlay G, Gagnon J, Horwitz M, Schier A, Shendure J . Whole-organism lineage tracing by combinatorial and cumulative genome editing. Science. 2016; 353(6298):aaf7907. PMC: 4967023. DOI: 10.1126/science.aaf7907. View